| Nasdaq: NURO
NeuroMetrix, Inc. designs and develops medical devices used for treatment of the neurological complications of diabetes. The company markets home use and point-of-care devices for the treatment and management of diabetic Neuropathies. It products include, NC-stat DPNCheck device, which is quantitative point-of-care test for diabetic neuropathy and is used to detect diabetic neuropathy at an early stage and to guide treatment; the SENSUS Pain Management System for treating chronic pain, focusing on physicians managing patients with painful diabetic neuropathy; ADVANCE System is designed for convenient nerve conduction studies in the office setting. NeuroMetrix was founded by Shai N. Gozani in June 1996 and is headquartered in Waltham, MA.